↓ Skip to main content

American Association for Cancer Research

BRAFV600E: Implications for Carcinogenesis and Molecular Therapy

Overview of attention for article published in Molecular Cancer Therapeutics, March 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
patent
4 patents

Citations

dimensions_citation
349 Dimensions

Readers on

mendeley
419 Mendeley
Title
BRAFV600E: Implications for Carcinogenesis and Molecular Therapy
Published in
Molecular Cancer Therapeutics, March 2011
DOI 10.1158/1535-7163.mct-10-0799
Pubmed ID
Authors

Emma R. Cantwell-Dorris, John J. O'Leary, Orla M. Sheils

Mendeley readers

The data shown below were compiled from readership statistics for 419 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 3 <1%
United Kingdom 2 <1%
Germany 1 <1%
India 1 <1%
South Africa 1 <1%
Brazil 1 <1%
Denmark 1 <1%
Spain 1 <1%
United States 1 <1%
Other 1 <1%
Unknown 406 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 76 18%
Student > Ph. D. Student 73 17%
Researcher 66 16%
Student > Master 48 11%
Other 25 6%
Other 68 16%
Unknown 63 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 102 24%
Agricultural and Biological Sciences 100 24%
Medicine and Dentistry 92 22%
Immunology and Microbiology 15 4%
Chemistry 11 3%
Other 32 8%
Unknown 67 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2021.
All research outputs
#1,690,976
of 22,788,370 outputs
Outputs from Molecular Cancer Therapeutics
#179
of 3,861 outputs
Outputs of similar age
#7,095
of 108,522 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#1
of 24 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,861 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,522 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.